243 related articles for article (PubMed ID: 35258278)
1. Isolation Methods Influence the Protein Corona Composition on Gold-Coated Iron Oxide Nanoparticles.
Hoang KNL; Wheeler KE; Murphy CJ
Anal Chem; 2022 Mar; 94(11):4737-4746. PubMed ID: 35258278
[TBL] [Abstract][Full Text] [Related]
2. Development of a fast and simple method for the isolation of superparamagnetic iron oxide nanoparticles protein corona from protein-rich matrices.
Soliman MG; Trinh DN; Ravagli C; Meleady P; Henry M; Movia D; Doumett S; Cappiello L; Prina-Mello A; Baldi G; Monopoli MP
J Colloid Interface Sci; 2024 Apr; 659():503-519. PubMed ID: 38184993
[TBL] [Abstract][Full Text] [Related]
3. Iron Oxide Nanoparticle Coatings Dictate Cell Outcomes Despite the Influence of Protein Coronas.
Portilla Y; Mellid S; Paradela A; Ramos-Fernández A; Daviu N; Sanz-Ortega L; Pérez-Yagüe S; Morales MP; Barber DF
ACS Appl Mater Interfaces; 2021 Feb; 13(7):7924-7944. PubMed ID: 33587585
[TBL] [Abstract][Full Text] [Related]
4. How protein coronas determine the fate of engineered nanoparticles in biological environment.
Capjak I; Goreta SŠ; Jurašin DD; Vrček IV
Arh Hig Rada Toksikol; 2017 Dec; 68(4):245-253. PubMed ID: 29337683
[TBL] [Abstract][Full Text] [Related]
5. Protein corona: implications for nanoparticle interactions with pulmonary cells.
Konduru NV; Molina RM; Swami A; Damiani F; Pyrgiotakis G; Lin P; Andreozzi P; Donaghey TC; Demokritou P; Krol S; Kreyling W; Brain JD
Part Fibre Toxicol; 2017 Oct; 14(1):42. PubMed ID: 29084556
[TBL] [Abstract][Full Text] [Related]
6. Evidence of protein coronas around soft nanoparticles regardless of the chemical nature of the outer surface: structural features and biological consequences.
de Castro CE; Panico K; Stangherlin LM; Albuquerque LJC; A S Ribeiro C; da Silva MCC; Jäger E; Giacomelli FC
J Mater Chem B; 2021 Mar; 9(8):2073-2083. PubMed ID: 33594396
[TBL] [Abstract][Full Text] [Related]
7. Preservation of the soft protein corona in distinct flow allows identification of weakly bound proteins.
Weber C; Simon J; Mailänder V; Morsbach S; Landfester K
Acta Biomater; 2018 Aug; 76():217-224. PubMed ID: 29885856
[TBL] [Abstract][Full Text] [Related]
8. Nano-Bio Interactions in Cancer: From Therapeutics Delivery to Early Detection.
Liu Y; Wang J; Xiong Q; Hornburg D; Tao W; Farokhzad OC
Acc Chem Res; 2021 Jan; 54(2):291-301. PubMed ID: 33180454
[TBL] [Abstract][Full Text] [Related]
9. Proteomic and Lipidomic Analysis of Nanoparticle Corona upon Contact with Lung Surfactant Reveals Differences in Protein, but Not Lipid Composition.
Raesch SS; Tenzer S; Storck W; Rurainski A; Selzer D; Ruge CA; Perez-Gil J; Schaefer UF; Lehr CM
ACS Nano; 2015 Dec; 9(12):11872-85. PubMed ID: 26575243
[TBL] [Abstract][Full Text] [Related]
10. Protein Corona Formation on Colloidal Polymeric Nanoparticles and Polymeric Nanogels: Impact on Cellular Uptake, Toxicity, Immunogenicity, and Drug Release Properties.
Obst K; Yealland G; Balzus B; Miceli E; Dimde M; Weise C; Eravci M; Bodmeier R; Haag R; Calderón M; Charbaji N; Hedtrich S
Biomacromolecules; 2017 Jun; 18(6):1762-1771. PubMed ID: 28511014
[TBL] [Abstract][Full Text] [Related]
11. Qualitative and semiquantitative analysis of the protein coronas associated to different functionalized nanoparticles.
Pederzoli F; Tosi G; Genovese F; Belletti D; Vandelli MA; Ballestrazzi A; Forni F; Ruozi B
Nanomedicine (Lond); 2018 Feb; 13(4):407-422. PubMed ID: 29345202
[TBL] [Abstract][Full Text] [Related]
12. Size Dependence Unveiling the Adsorption Interaction of High-Density Lipoprotein Particles with PEGylated Gold Nanoparticles in Biomolecular Corona Formation.
Jang GJ; Jeong JY; Kang J; Cho W; Han SY
Langmuir; 2021 Aug; 37(32):9755-9763. PubMed ID: 34347501
[TBL] [Abstract][Full Text] [Related]
13. In Situ Characterization of Protein Adsorption onto Nanoparticles by Fluorescence Correlation Spectroscopy.
Shang L; Nienhaus GU
Acc Chem Res; 2017 Feb; 50(2):387-395. PubMed ID: 28145686
[TBL] [Abstract][Full Text] [Related]
14. The importance of selecting a proper biological milieu for protein corona analysis in vitro: Human plasma versus human serum.
Mirshafiee V; Kim R; Mahmoudi M; Kraft ML
Int J Biochem Cell Biol; 2016 Jun; 75():188-95. PubMed ID: 26643610
[TBL] [Abstract][Full Text] [Related]
15. How Corona Formation Impacts Nanomaterials as Drug Carriers.
Gupta MN; Roy I
Mol Pharm; 2020 Mar; 17(3):725-737. PubMed ID: 31939673
[TBL] [Abstract][Full Text] [Related]
16. Dispersion of Nanoparticles in Different Media Importantly Determines the Composition of Their Protein Corona.
Strojan K; Leonardi A; Bregar VB; Križaj I; Svete J; Pavlin M
PLoS One; 2017; 12(1):e0169552. PubMed ID: 28052135
[TBL] [Abstract][Full Text] [Related]
17. The interaction between nanoparticles-protein corona complex and cells and its toxic effect on cells.
Liu N; Tang M; Ding J
Chemosphere; 2020 Apr; 245():125624. PubMed ID: 31864050
[TBL] [Abstract][Full Text] [Related]
18. A method to measure the denatured proteins in the corona of nanoparticles based on the specific adsorption of Hsp90ab1.
Liu S; Jiang X; Tian X; Wang Z; Xing Z; Chen J; Zhang J; Wang C; Dong L
Nanoscale; 2020 Aug; 12(29):15857-15868. PubMed ID: 32696774
[TBL] [Abstract][Full Text] [Related]
19. Potential clinical applications of the personalized, disease-specific protein corona on nanoparticles.
García Vence M; Chantada-Vázquez MDP; Vázquez-Estévez S; Manuel Cameselle-Teijeiro J; Bravo SB; Núñez C
Clin Chim Acta; 2020 Feb; 501():102-111. PubMed ID: 31678275
[TBL] [Abstract][Full Text] [Related]
20. Polymer-coated nanoparticle protein corona formation potentiates phagocytosis of bacteria by innate immune cells and inhibits coagulation in human plasma.
Ortega VA; Bahniuk MS; Memon S; Unsworth LD; Stafford JL; Goss GG
Biointerphases; 2020 Sep; 15(5):051003. PubMed ID: 32957792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]